Cargando…
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis
Atherothrombotic stroke represents approximately 20% of all ischemic strokes. It is caused by large-artery atherosclerosis, mostly in the internal carotid artery, and it is associated with a high risk of early recurrence. After an ischemic stroke, tissue plasminogen activator is used in clinical pra...
Autores principales: | Puig, Núria, Solé, Arnau, Aguilera-Simon, Ana, Griñán, Raquel, Rotllan, Noemi, Camps-Renom, Pol, Benitez, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531661/ https://www.ncbi.nlm.nih.gov/pubmed/37762627 http://dx.doi.org/10.3390/ijms241814325 |
Ejemplares similares
-
Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
por: Puig, Núria, et al.
Publicado: (2023) -
Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability
por: Puig, Núria, et al.
Publicado: (2020) -
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by (18)F-FDG PET in patients with a recent ischemic stroke
por: Garcia, Eduardo, et al.
Publicado: (2023) -
Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke
por: Puig, Núria, et al.
Publicado: (2022) -
Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)